Evidence map›Paper›PMID 32373597›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Developing a Multi-Layer Deep Learning Based Predictive Model to Identify DNA N4-Methylcytosine Modifications.

Rao Zeng, Minghong Liao

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. EnDeep4mC predicts DNAGenome research · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rao ZengDepartment of Software Engineering, School of Informatics, Xiamen University, Xiamen, China.
Minghong LiaoDepartment of Software Engineering, School of Informatics, Xiamen University, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA N4-methylcytosine modification (4mC) plays an essential role in a variety of biological processes. Therefore, accurate identification the 4mC distribution in genome-scale is important for systematically understanding its biological functions. In this study, we present Deep4mcPred, a multi-layer deep learning based predictive model to identify DNA N4-methylcytosine modifications. In this predictor, we for the first time integrate residual network and recurrent neural network to build a multi-layer deep learning predictive system. As compared to existing predictors using traditional machine learning, our proposed method has two advantages. First, our deep learning framework does not need to specify the features when training the predictive model. It can automatically learn the high-level features and capture the characteristic specificity of 4mC sites, benefiting to distinguish true 4mC sites from non-4mC sites. On the other hand, our deep learning method outperforms the traditional machine learning predictors in performance by benchmarking comparison, demonstrating that the proposed Deep4mcPred is more effective in the DNA 4mC site prediction. Moreover, via experimental comparison, we found that attention mechanism introduced into the deep learning framework is useful to capture the critical features. Additionally, we develop a webserver implementing the proposed method for the academic use of research community, which is now available at http://server.malab.cn/Deep4mcPred.

Indexed as

deep learningDNA N4-methylcytosinefeature representationsite predictionwebserver

Identifiers

PMID32373597
PMCPMC7186498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.